Boutron-Ruault MC - Search Results

1

Asthma Medication Ratio Phenotypes in Elderly Women.

Chanoine S, Pin I, Sanchez M, Temam S, Pison C, Le Moual N, Severi G, Boutron-Ruault MC, Fournier A, Bousquet J, Bedouch P, Varraso R, Siroux V. Chanoine S, et al. J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):897-906.e5. doi: 10.1016/j.jaip.2017.07.014. Epub 2017 Sep 22. J Allergy Clin Immunol Pract. 2018. PMID: 28958739

2

Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status.

Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. Touillaud MS, et al. J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. doi: 10.1093/jnci/djk096. J Natl Cancer Inst. 2007. PMID: 17374837 Free PMC article.

3

Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?

Vercambre MN, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F, Ringa V, Berr C. Vercambre MN, et al. Am J Epidemiol. 2007 Dec 15;166(12):1451-60. doi: 10.1093/aje/kwm162. Epub 2007 Aug 13. Am J Epidemiol. 2007. PMID: 17698505

4

Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women.

Kvaskoff M, Mesrine S, Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Kvaskoff M, et al. Arch Intern Med. 2007 Oct 22;167(19):2061-5. doi: 10.1001/archinte.167.19.2061. Arch Intern Med. 2007. PMID: 17954799 Free PMC article.

5

Risk of onset of menopausal symptoms in periods surrounding menopause.

Sabia S, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Sabia S, et al. Maturitas. 2007 Dec 20;58(4):340-7. doi: 10.1016/j.maturitas.2007.09.012. Epub 2007 Nov 5. Maturitas. 2007. PMID: 17981410

6

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F. Fournier A, et al. J Clin Oncol. 2008 Mar 10;26(8):1260-8. doi: 10.1200/JCO.2007.13.4338. J Clin Oncol. 2008. PMID: 18323549 Free PMC article.

7

Risk factors for onset of menopausal symptoms: results from a large cohort study.

Sabia S, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Sabia S, et al. Maturitas. 2008 Jun 20;60(2):108-21. doi: 10.1016/j.maturitas.2008.04.004. Epub 2008 May 29. Maturitas. 2008. PMID: 18513898

8

Progestagens use before menopause and breast cancer risk according to histology and hormone receptors.

Fabre A, Fournier A, Mesrine S, Gompel A, Desreux J, Berrino F, Boutron-Ruault MC, Romieu I, Clavel-Chapelon F. Fabre A, et al. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2723-8. doi: 10.1158/1055-9965.EPI-08-0056. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18843015

9

Breast cancer and hormonal therapy in postmenopausal women.

Fournier A, Boutron-Ruault MC, Clavel-Chapelon F. Fournier A, et al. N Engl J Med. 2009 May 28;360(22):2366; author reply 2366-7. doi: 10.1056/NEJMc090490. N Engl J Med. 2009. PMID: 19474437 No abstract available.

10

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Fournier A, et al. J Clin Oncol. 2009 Nov 1;27(31):5138-43. doi: 10.1200/JCO.2008.21.6432. Epub 2009 Sep 14. J Clin Oncol. 2009. PMID: 19752341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

719 results

Search Page